SEC Filing Details

Document Details

Form
Filing Date
Jul 17, 2019
Document Date
Jul 15, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
GOEDDEL DAVID V

Stock Quote

Contact Information

Investor Relations:
ir@ngmbio.com

Media Relations:
media@ngmbio.com

Top